(Q44486478)

3 December 2017

Imaging 26S proteasome activity and inhibition in living mice (English)

1 reference

3 December 2017

Kathryn E Luker

4

0 references

David Piwnica-Worms

series ordinal

5

object named as

David Piwnica-Worms

1 reference

3 December 2017

Gary D Luker

1

1 reference

3 December 2017

Christina M Pica

series ordinal

2

1 reference

3 December 2017

Jiling Song

series ordinal

3

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 December 2017

1 reference

3 December 2017

9

1 reference

3 December 2017

969-973

1 reference

3 December 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/nm894

3 December 2017

0 references

cites work

Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategies

1 reference

7 January 2021

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

1 reference

7 January 2021

Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury

1 reference

7 January 2021

Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia

1 reference

7 January 2021

Proteasome inhibitors as new anticancer drugs

1 reference

7 January 2021

Molecular mechanisms of novel therapeutic approaches for multiple myeloma

1 reference

7 January 2021

The 26S proteasome: a molecular machine designed for controlled proteolysis

1 reference

7 January 2021

Proteins are unfolded on the surface of the ATPase ring before transport into the proteasome

1 reference

7 January 2021

Multiple associated proteins regulate proteasome structure and function

1 reference

7 January 2021

A ubiquitin-based tagging system for controlled modulation of protein stability

1 reference

7 January 2021

Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex.

1 reference

7 January 2021

Proteasome inhibitors reduce luciferase and beta-galactosidase activity in tissue culture cells

1 reference

7 January 2021

Proteasome inhibitors: from research tools to drug candidates

1 reference

7 January 2021

Crystal structure of calcium bound domain VI of calpain at 1.9 A resolution and its role in enzyme assembly, regulation, and inhibitor binding

1 reference

7 January 2021

Reporter gene expression for monitoring gene transfer

1 reference

7 January 2021

Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells

1 reference

7 January 2021

Proteasome inhibition: a novel approach to cancer therapy

1 reference

7 January 2021

Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies

1 reference

7 January 2021

Impairment of the ubiquitin-proteasome system by protein aggregation

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM894

1 reference

Dimensions Publication ID

3 December 2017

0 references

1 reference